Fairmount Healthcare Fund II L.P.
CIK 1769651
Transactions on file
13
Open-market buys
5
Win rate (buys)
80%
5 scored
Avg % since filing (buys)
+14.3%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-20 | 2026-07-16 | CBIO CRESCENT BIOPHARMA, INC. | Director10% | Buy | 853,450 | $12.38M | +3.6% | open → |
| 2026-07-02 | 2026-07-01 | ORKA Oruka Therapeutics, Inc. | Director10% | Sale | 3,553,410 | $300.01M | +15.9% | open → |
| 2026-07-02 | 2026-07-01 | ORKA Oruka Therapeutics, Inc. | Director10% | C | 3,553,410 | $0.00 | — | open → |
| 2026-06-24 | 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Director | Sale | 4,684,781 | $399.66M | +19.0% | open → |
| 2026-06-24 | 2026-06-23 | SYRE Spyre Therapeutics, Inc. | Director | C | 666,680 | $0.00 | — | open → |
| 2026-05-13 | 2026-05-11 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Buy | 1,176,470 | $20.00M | +17.1% | open → |
| 2025-06-11 | 2025-06-10 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Exer. | 12,500 | $153.9K | +61.7% | open → |
| 2025-06-11 | 2025-06-09 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Exer. | 1,600 | $12.5K | +155.1% | open → |
| 2025-12-08 | 2025-12-04 | CBIO CRESCENT BIOPHARMA, INC. | Director10% | Buy | 1,360,000 | $18.24M | +12.0% | open → |
| 2025-10-27 | 2025-10-23 | VRDN Viridian Therapeutics, Inc.\DE | Director10% | Buy | 454,545 | $10.00M | -9.5% | open → |
| 2025-10-09 | 2025-10-07 | ZBIO Zenas BioPharma, Inc. | Director | Buy | 316,219 | $6.01M | +48.6% | open → |
| 2025-10-08 | 2025-10-06 | JBIO Jade Biosciences, Inc. | Director10% | Grant | 1,333,126 | $12.18M | +119.7% | open → |
| 2025-09-19 | 2025-09-17 | ORKA Oruka Therapeutics, Inc. | Director10% | Grant | 333,340 | $5.00M | +552.4% | open → |
